WELCOME TO OPTOGENETICS AUSTRALIA

Optogenetics Australia was established to support the application and development of optogenetics and to deliver benefits of the technology to research in academia and industry in Australia. This network will foster exchange and collaboration by connecting research groups working in the field and by organizing an annual workshop. Find out more about optogenetics and investigators in Australia (including the occasional open position)! Impressions of the 2021 Workshop (held 16-19 February, 2021) can be found here. We thank our speakers, participants and sponsor for a great event!

Applications of optogenetics are rapidly expanding in research and therapy:

>6000

Publications in PubMed

2006-2020:

„Optogenetic(s)“ in title/abstract

>800

mentions in WIPO Patent(s) (applications)

August 2020:

http://patents.google.com/?q=optogenetics&country=WO

THREE

Clinical Trials using ChR

August 2020:

http://clinicaltrials.gov/ct2/results?term=channelrhodopsin

For inquiries or if you would like to contribute to Optogenetics Australia, please contact Harald Janovjak (Monash University, chair) by email.

Optogenetics Australia advisory board: Zane Andrews (Monash University), Chris Dayas (University of Newcastle), Wendy Imlach (Monash University), Mark Hutchinson (University of Adelaide), Abbas Kouzani (Deakin University), John Lin (University of Tasmania), Gavan McNally (University of New South Wales), Ethan Scott (University of Queensland), Alexandra Tichy (Monash University)